Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay

Journal of Immunological Methods

Volumn 337, Issue 2, 2008, Pages 132-143

  Jacques, Nathalie ^a   Vimond, Nadege ^a   Conforti, Rosa ^a   Griscelli, Franck ^a   Lecluse, Yann ^a   Laplanche, Agnes ^a   Malka, David ^a   Vielh, Philippe ^a   Farace, Françoise ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Anti angiogenic agents; Biomarker; Circulating endothelial cells; Flow cytometry

Indexed keywords

7 AMINODACTINOMYCIN; BIOLOGICAL MARKER; CD146 ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; IMMUNOGLOBULIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BLOOD; CELL ASSAY; CELL MATURATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; STAINING; STATISTICAL ANALYSIS;

ANGIOGENESIS INHIBITORS; ANTIGENS, CD; BIOLOGICAL MARKERS; BLOOD CELL COUNT; CADHERINS; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING;

EID: 49449113237     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.07.006     Document Type: Article

References (32)

1. Batchelor T.T., Sorensen A.G., di Tomaso E., Zhang W.T., Duda D.G., Cohen K.S., Kozak K.R., Cahill D.P., Chen P.J., Zhu M., Ancukiewicz M., Mrugala M.M., et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cells 11 (2007) 83
2. Beaudry P., Force J., Naumov G.N., Wang A., Baker C.H., Ryan A., Soker S., Johnson B.E., Folkman J., and Heymach J.V. Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity. Clin. Cancer Res. 11 (2005) 3514
3. Bertolini F., Shaked Y., Mancuso P., and Kerbel R.S. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev., Cancer 6 (2006) 835
4. Beerepoot L.V., Radema S.A., Witteveen E.O., Thomas T., Wheeler C., Kempin S., and Voest E.E. Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. J. Clin. Oncol. 24 (2006) 1491
5. Bhatt R.S., Seth P., and Sukhatme V.P. Biomarkers for monitoring antiangiogenic therapy. Clin. Cancer Res. 13 (2007) 777s
6. Blann A.D., Woywodt A., Bertolini F., Bull T.M., Buyon J.P., Clancy R.M., Haubitz M., Hebbel R.P., Lip G.Y., Mancuso P., Sampol J., Solovey A., and Dignat-George F. Circulating endothelial cells biomarker of vascular disease. Thromb. Haemost. 93 (2005) 228
7. Dignat-George F. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B, Clin. Cytom. 70 (2006) 104
8. Dignat-George F., and Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur. J. Haematol. 65 (2000) 215
9. Dignat-George F., Sampol J., Lip G., and Blann A.D. Circulating endothelial cells: realities and promises in vascular disorders. Pathophysiol. Haemost. Thromb. 33 (2003) 495
10. Dignat-George F., Sabatier F., Blann A., and Woywodt A. Detection of circulating endothelial cells: CD146-based magnetic separation enrichment or flow cytometric assay?. J. Clin. Oncol. 25 (2007) e1
11. Duda D.G., Cohen K.S., di Tomaso E., Au P., Klein R.J., Scadden D.T., Willett C.G., and Jain R.K. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J. Clin. Oncol. 24 (2006) 1449
12. Duda D.G., Cohen K.S., Au P., Scadden D.T., Willet C.G., and Jain R.K. In reply. J. Clin. Oncol. 25 (2007) e3
13. George F., Brisson C., Poncelet P., Laurent J.C., Massot O., Arnoux D., Ambrosi P., Klein-Soyer C., Cazenave J.P., and Sampol J. Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty. Thromb. Haemost. 67 (1992) 147
14. George F., Brouqui P., Boffa M.C., Mutin M., Drancourt M., Brisson C., Raoult D., and Sampol J. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82 (1993) 2109
15. Goon P.K., Lip G.Y., Boos C.J., Stonelake P.S., and Blann A.D. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 8 (2006) 79
16. Goon P.K., Boos C.J., Stonelake P.S., Blann A.D., and Lip G.Y. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison. Thromb. Haemost. 96 (2006) 45
17. Jubb A.M., Oates A.J., Holden S., and Koeppen H. Predicting benefit from anti-angiogenic agents in malignancy. Nat. Rev., Cancer 6 (2006) 626
18. Kerbel R.S., and Folkman J. Clinical translation of angiogenesis inhibitors. Nat. Rev., Cancer 2 (2002) 727
19. Khan S.S., Solomon M.A., and McCoy Jr. J.P. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B, Clin. Cytom. 64 (2005) 1
20. Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 7 (2001) 1194
21. Mancuso P., Burlini A., Pruneri G., Goldhirsch A., Martinelli G., and Bertolini F. Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97 (2001) 3658
22. Mancuso P., Colleoni M., Calleri A., Orlando L., Maisonneuve P., Pruneri G., Agliano A., Goldhirsch A., Shaked Y., Kerbel R.S., and Bertolini F. Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy. Blood 108 (2006) 452
23. Monestiroli S., Mancuso P., Burlini A., Pruneri G., Dell'Agnola C., Gobbi A., Martinelli G., and Bertolini F. Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma. Cancer Res. 61 (2001) 4341
24. Mutin M., Dignat-George F., and Sampol J. Immunologic phenotype of cultured endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens 50 (1997) 449
25. Rafii S., Lyden D., Benezra R., Hattori K., and Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat. Rev., Cancer 2 (2002) 826
26. Rowand J.L., Martin G., Doyle G.V., Miller M.C., Pierce M.S., Connelly M.C., Rao C., and Terstappen L.W. Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 71 (2007) 105
27. Shaked Y., Bertolini F., Man S., Rogers M.S., Cervi D., Foutz T., Rawn K., Voskas D., Dumont D.J., Ben-David Y., Lawler J., Henkin J., et al. Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. Cancer Cells 7 (2005) 101
28. Strijbos M.H., Kraan J., den Bakker M.A., Lambrecht B.N., Sleijfer S., and Gratama J.W. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B, Clin. Cytom. 72B (2007) 86
29. Vroling L., Yuana Y., Schuurhuis G.J., Van Hinsberg V.W.M., Gundry C., De Haas R., Van Cruijen H., Boven E., Hoekman K., and Broxterman H.J. VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients. Thromb. Haemost. 98 (2007) 440
30. Wideman A., Sabatier F., Arnaud L., Bonello L., AL-Massarani G., Paganelli F., Poncelet P., and Dignat-George F. CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells. J. Thromb. Haemost. 6 (2008) 869
31. Willett C.G., Boucher Y., di Tomaso E., Duda D.G., Munn L.L., Tong R.T., Chung D.C., Sahani D.V., Kalva S.P., Kozin S.V., Mino M., Cohen K.S., et al. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 10 (2004) 145
32. Woywodt A., Blann A.D., Kirsch T., Erdbruegger U., Banzet N., Haubitz M., and Dignat-George F. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J. Thromb. Haemost. 4 (2006) 671